바이오솔루션

086820KOSDAQ

51.1 / 100

Reference Date: 2026-09-08

Financial Score13.5 / 40

News Sentiment20.6 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Rose 7.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

BioSolution is a biotech company specializing in the research, development, and commercialization of advanced biopharmaceuticals, human tissue models, and biofusion materials based on stem cell and tissue engineering technologies. Key products include Kerahil for burn treatment and Catilife for cancer therapy, with OECD and ISO certifications enabling entry into alternative toxicity testing markets. The company also leads the clean and vegan cosmetics market through biofusion materials derived from plant stem cells and natural substances.

Number of Employees

100people

Average Salary

57.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

581.82Industry Average 15.000.0Point

38.8x industry avg (risky)

PBR

5.18Industry Average 1.200.0Point

4.3x industry avg (risky)

ROE

0.86Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

7.08Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.7% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲6.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -11.5% (improving, 3yr)

Detailed News Sentiment

17 totalPositive 16Neutral 1Negative 0Average Sentiment Score 82.4

Positive
골관절염 환자 10억명 시대…로킷헬스케어·바이오솔루션 주목-그로쓰...
고령화 추세 속 골관절염 환자 증가로 인해 국소 연골재생 기술을 보유한 바이오솔루션의 성장 잠재력이 높아지고 있다.
Positive
“독자개발 항산화 효소로 헬스케어 기업 전환 속도”
바이오솔루션의 새로운 항산화 효소 '소디자임'을 통해 아시아 시장 진출 확대 및 건강 제품 다각화 전략이 긍정적으로 평가됨.
Positive
"AI칩 뜰수록 열 통제 더 중요 … 한국과 소재 공동 개발할 것"
바이오솔루션 관련 AI 칩 열 관리 기술 강화로 글로벌 시장 확장 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 6,400Won52-week high 12,95052-week low 5,510

1-month return5.0Point

1m +7.20% (rising)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14